Qube Research & Technologies (QRT)
SNDX icon

Qube Research & Technologies (QRT)’s Syndax Pharmaceuticals SNDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
477,182
+441,135
+1,224% +$9.17M 0.01% 1262
2026
Q1 		$842K Sell
36,047
-652,090
-95% -$14.2M ﹤0.01% 2563
2025
Q4 		$14.5M Sell
688,137
-956,707
-58% -$16.7M 0.01% 1099
2025
Q3 		$25.3M Sell
1,644,844
-21,072
-1% -$276K 0.03% 783
2025
Q2 		$15.6M Buy
1,665,916
+831,067
+100% +$9.15M 0.02% 1022
2025
Q1 		$10.3M Buy
834,849
+110,433
+15% +$1.56M 0.01% 1127
2024
Q4 		$9.58M Buy
724,416
+41,214
+6% +$705K 0.01% 1115
2024
Q3 		$13.2M Buy
683,202
+385,899
+130% +$7.97M 0.02% 875
2024
Q2 		$6.1M Buy
297,303
+203,414
+217% +$4.26M 0.01% 1172
2024
Q1 		$2.23M Buy
93,889
+36,528
+64% +$815K ﹤0.01% 1692
2023
Q4 		$1.24M Sell
57,361
-149,033
-72% -$2.29M ﹤0.01% 1802
2023
Q3 		$3M Buy
206,394
+75,636
+58% +$1.43M 0.01% 1176
2023
Q2 		$2.74M Buy
130,758
+90,147
+222% +$1.88M 0.01% 919
2023
Q1 		$858K Buy
+40,611
New +$1.01M ﹤0.01% 1352
2022
Q2 		– Sell
-42,073
Closed -$731K – 3084
2022
Q1 		$731K Buy
+42,073
New +$708K 0.01% 1336
2020
Q3 		– Sell
-20,852
Closed -$309K – 2074
2020
Q2 		$309K Buy
+20,852
New +$318K ﹤0.01% 1286

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SNDX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Syndax Pharmaceuticals (SNDX) stake by 1,224% in Q2 2026, buying an estimated $9.17M and bringing the position to 477,182 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #1262.

Qube Research & Technologies (QRT) first reported a position in SNDX in Q2 2020 and has held it in 16 quarters since. The position peaked at $25.3M in Q3 2025. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 477,182 shares of Syndax Pharmaceuticals worth $10.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 441,135 Syndax Pharmaceuticals shares in Q2 2026, an estimated $9.17M.
  • Syndax Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1262 holding.
  • Qube Research & Technologies (QRT) first reported a position in Syndax Pharmaceuticals in Q2 2020 and has held it in 16 quarters since.
  • Qube Research & Technologies (QRT)'s Syndax Pharmaceuticals position peaked at $25.3M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.